A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
| Image |  |
|---|---|
| Description | scientific article published on 18 April 2017 |
| Author/s |
author: Besim Ogretmen |
| Publication date | April 18, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |